| Bioactivity | LGD-6972 sodium is a selective and orally active glucagon receptor antagonist. LGD-6972 sodium has the potential for type 2 diabetes research[1]. |
| CAS | 1207989-22-7 |
| Formula | C43H45N2NaO5S |
| Molar Mass | 724.88 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Vajda EG, et al. Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus. Diabetes Obes Metab. 2017 Jan;19(1):24-32. |
LGD-6972 sodium
CAS: 1207989-22-7 F: C43H45N2NaO5S W: 724.88
LGD-6972 sodium is a selective and orally active glucagon receptor antagonist. LGD-6972 sodium has the potential for typ
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.